Teva ADR Earnings Exceed Estimates by $0.06, Revenue Surpasses Projections

Teva ADR recently announced its second-quarter earnings, reporting earnings per share (EPS) of $0.61, surpassing analyst expectations of $0.55. The company’s revenue for the quarter reached $4.2 billion, exceeding the consensus estimate of $4.06 billion.

### Guidance

For the fiscal year 2024, Teva ADR projects an EPS range of $2.30 to $2.50, slightly below the analyst consensus of $2.46. Additionally, the company expects its revenue for the same year to fall between $16.00 billion and $16.40 billion, compared to the consensus estimate of $15.99 billion.

Teva ADR’s stock closed at $16.41 and has increased by 17.38% over the past three months, and an impressive 97.95% over the last year. In the past 90 days, the company has experienced zero positive EPS revisions while facing four negative revisions.

According to financial analysis, Teva ADR’s financial health is rated as “great performance.” Keep informed about future earnings reports to stay updated on the company’s financial progress.